Back
Norfolk Southern 10K Form
Buy
60
NSC
Norfolk Southern
Last Price:
247.43
Seasonality Move:
4.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | NSC/Norfolk Southern Quarterly |
2024-02-05 | 10K | NSC/Norfolk Southern Annual |
2023-10-25 | 10Q | NSC/Norfolk Southern Quarterly |
2023-07-27 | 10Q | NSC/Norfolk Southern Quarterly |
2023-04-26 | 10Q | NSC/Norfolk Southern Quarterly |
2023-02-03 | 10K | NSC/Norfolk Southern Annual |
Receive NSC News And Ratings
See the #1 stock for the next 7 days that we like better than NSC
NSC Financial Statistics
Sales & Book Value
Annual Sales: | $12.16B |
---|---|
Cash Flow: | $468M |
Price / Cash Flow: | 81.62 |
Annual Sales: | $57.40 |
Price / Book: | 4.28 |
Profitability
EPS (TTM): | 7.90000 |
---|---|
Net Income (TTM): | $1.8B |
Gross Margin: | $4.44B |
Return on Equity: | 14.12% |
Return on Assets: | 4.35% |
Norfolk Southern Earnings Forecast
Key Norfolk Southern Financial Ratios
- The Gross Profit Margin over the past 40 years for NSC is 36.48%.
- The Selling, General & Administrative Expenses for NSC have been equal to -0.53% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 39.52% of Operating Income.
- The Net Earning history of NSC is 15.03% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 25 years.
Norfolk Southern Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Ground Transportation |
Sector: | Industrials |
Current Symbol: | NSC |
CUSIP: | 655844 |
Website: | norfolksouthern.com |
Debt
Debt-to-Equity Ratio: | 1.36 |
---|---|
Current Ratio: | 0.63 |
Quick Ratio: | 0.5 |
Price-to-Earnings
Trailing P/E Ratio: | 30.65 |
---|---|
Forward P/E Ratio: | 17.95 |
NSC Technical Analysis vs Fundamental Analysis
Buy
60
Norfolk Southern (NSC)
is a Buy
Is Norfolk Southern a Buy or a Sell?
-
Norfolk Southern stock is rated a Buy
The current Norfolk Southern [NSC] share price is $245.80. The Score for NSC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.